Related Experiment Video
Updated: May 8, 2026
07:09
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Molecular pathways: targeting MALT1 paracaspase activity in lymphoma
1Authors' Affiliations: Departments of Medicine and Pharmacology, Weill Cornell Medical College, New York, New York.
Summary
Mucosa-Associated Lymphoid Tissue 1 (MALT1) is crucial for NF-κB activation and B-cell lymphoma growth. MALT1 inhibitors show promise for treating B-cell lymphomas and autoimmune diseases.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- MALT1 (Mucosa-Associated Lymphoid Tissue 1) is essential for NF-κB pathway activation via antigen receptor signaling.
- MALT1 acts as a scaffolding protein with BCL10 and CARD11 to activate the IKK complex.
- MALT1 possesses paracaspase activity regulating NF-κB signaling feedback loops.
Purpose of the Study:
- To review recent advances in the functions of MALT1 in normal physiology and disease.
- To explore the therapeutic potential of targeting MALT1 activity.
Main Methods:
- Literature review focusing on MALT1's role in NF-κB signaling.
- Analysis of MALT1's involvement in activated B-cell subtype of diffuse large B-cell lymphomas (ABC-DLBCL).
- Evaluation of MALT1 small-molecule inhibitors' efficacy.
Main Results:
- MALT1 activity is critical for ABC-DLBCL proliferation and chemoresistance.
- MALT1 small-molecule inhibitors demonstrate efficacy in suppressing ABC-DLBCL growth in vitro and in vivo.
- Targeting MALT1 proteolytic activity is a viable therapeutic strategy.
Conclusions:
- MALT1 is a key regulator of B-cell activation and a potential therapeutic target.
- MALT1 inhibitors offer a promising avenue for treating B-cell lymphomas.
- MALT1 inhibition may also benefit autoimmune diseases driven by aberrant lymphocyte signaling.
More Related Videos
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...